NICE issues guidance for use of pemetrexed disodium for the treatment of malignant pleural mesothelioma (TA 135)

Abstract The National Institute for Health and Clinical Excellence (NICE) has issued a Technology Appraisal for the use of pemetrexed for the treatment of malignant pleural mesothelioma, and makes the following recommendations (taken directly from source):

• Pemetrexed is recommended as a treatment option for malignant pleural mesothelioma only in people who have a World Health Organisation (WHO) performance status of 0 or 1, who are considered to have advanced disease and for whom surgical resection is considered inappropriate

• Patients currently receiving pemetrexed who do not fall into the patient population defined above should have the option to continue therapy until they and their clinicians consider it appropriate to stop.

Source - NICE

To contact one of our specialist lawyers please call 0800 61 66 81, or use the contact details at the top left of this page.

What our clients say about us...

"After calling you we were impressed that you were prepared to meet us at home the next day. This personal visit, in my mind, set the tone of our relationship. Over the course of two and a half years, you were professional, caring, and represented our best interests. Our lawyer was always mindful of my husband's condition. When you gathered information from him, you always inquired first about how he was feeling and if I felt he was up to talking with you, an attitude we did not expect from a law practice. Your work has allowed us to be financially secure and focus on the continuing programme of chemotherapy." Mrs M Simpson, Worthing

Click here to see how we can help...

Questions answered online within 30 minutes

Specialised lawyer

Answered for free

No commitment

Find out more

Working with:

News centre